A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

CV Therapeutics

About CV Therapeutics:

CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases. (NASDAQ:CVTX)

The company is pioneering a new biomedical discipline, molecular cardiology, which applies advances in molecular biology and genetics to identify mechanisms of cardiovascular disease that may lead to new targets for drug discovery. By using novel, small molecules against these disease targets, CV Therapeutics is building a pipeline of potential products that are designed to offer improved efficacy and/or fewer side effects compared with existing agents.


Product Pipeline Data for CV Therapeutics


Ranexa (Chronic Angina);
(Myocardial Perfusion Imaging);
(PSVT Atrial Fibrillation);
Adentri (congestive heart failure--CHF)


NIH Data for Trials CV Therapeutics


More on CV Therapeutics :

Home Page

Key Statistics for CV Therapeutics

Basic Chart for CV Therapeutics

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.